Tenet Healthcare Corporation
NYSE:THCMedical - Care Facilities
-$5.06 today
- Market cap
- $21.60B
- Beta
- 1.28
- P/E (TTM)
- 9.1
- EPS (TTM)
- $19.62
Volume 1.57M
Average 1.41M
THC Net Receivables
Amounts owed to the company by customers and others, net of allowances for uncollectible accounts.
Tenet Healthcare CorporationNYSE: THC
Net Receivables · Q2 FY2026 · quarter ended Jun 2026
Net receivables falls 29.5% from a year ago
Net receivables stood at $2.61B at the end of Q2 FY2026, down 29.5% from a year earlier and up 0.1% from the prior quarter. Over 3 fiscal years it compounded at -9.5% a year.
Context
- Net receivables amounted to 8.5% of total assets at the end of Q2 FY2026, down 4.4 pp from a year earlier.
- Net receivables increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether net receivables keeps falling in the next quarterly balance sheet after a -29.5% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Net Receivables history
USD · from the balance sheet
- Latest · FY2025
- 2.57B USD
- Year-over-year change
- -16.0%
- 4-year CAGR
- -6.1%
| Period | Period end | Net Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 2.57B | -16.0% |
| FY2024 | 2024-12-31 | 3.05B | -10.3% |
| FY2023 | 2023-12-31 | 3.4B | -1.7% |
| FY2022 | 2022-12-31 | 3.46B | +4.7% |
| FY2021 | 2021-12-31 | 3.31B | — |
Net Receivables vs competitors
How THC compares with its peers on the latest reported figures
- THC's Jun 2026 net receivables of $2.61B is the 3rd highest of the 7 companies compared; the peer median is $1.54B.
- Its year-over-year change of -29.5% is the lowest of 7, against a peer median of +5.2%.
- Net receivables amounts to 8.5% of total assets for THC, versus a peer median of 15.5%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $12.28B | +17.4% | +6.9% | 20.3% | |
| Jun 2026 | $2.8B | +21.7% | +8.9% | 17.6% | |
| Jun 2026 | $2.61B | -29.5% | -9.5% | 8.5% | |
| Mar 2026 | $2.37B | -4.4% | +1.9% | 17.9% | |
ARDTArdent Health Partners, LLC | Mar 2026 | $709.19M | -8.7% | +3.9% | 13.5% |
| Sep 2026 | $468.1M | -19.2% | +9.7% | 6.6% | |
CONConcentra Group Holdings Parent, Inc. | Sep 2026 | $320.26M | +14.8% | +7.7% | 10.6% |
| Peer median (excluding THC) | $1.54B | +5.2% | +7.3% | 15.5% | |
Competitors are the stored peer set for THC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 2.36B | 858M | 1.23B | 3.02B | 2.88B |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 3.31B | 3.46B | 3.4B | 3.05B | 2.57B |
| Inventory | 384M | 405M | 411M | 346M | 348M |
| Other Current Assets | 769M | 856M | 1.73B | 895M | 2.05B |
| Total Current Assets | 7.08B | 5.98B | 7.17B | 7.68B | 7.85B |
| Property, Plant & Equipment (Net) | 7.43B | 7.59B | 7.32B | 7.09B | 7.45B |
| Goodwill | 9.26B | 10.12B | 10.31B | 10.69B | 11.2B |
| Intangible Assets | 1.5B | 1.42B | 1.37B | 1.4B | 1.35B |
| Long-term Investments | 2.03B | 1.83B | 1.89B | 1.81B | 1.44B |
| Tax Assets | 65M | 19M | 77M | 80M | 84M |
| Other Non-current Assets | 224M | 192M | 180M | 194M | 307M |
| Total Non-current Assets | 20.5B | 21.18B | 21.15B | 21.25B | 21.83B |
| Total Assets | 27.58B | 27.16B | 28.31B | 28.94B | 29.68B |
| Account Payables | 1.3B | 1.5B | 1.41B | 1.29B | 1.36B |
| Short-term Debt | 135M | 145M | 120M | 296M | 79M |
| Tax Payables | 0 | 0 | 23M | 18M | 0 |
| Deferred Revenue | 959M | 110M | 0 | 0 | 0 |
| Other Current Liabilities | 2.51B | 2.5B | 3.01B | 2.55B | 1.81B |
| Total Current Liabilities | 5.11B | 4.48B | 4.76B | 4.31B | 4.46B |
| Long-term Debt | 15.51B | 14.93B | 14.88B | 12.69B | 13.09B |
| Deferred Tax Liabilities | 36M | 217M | 326M | 227M | 240M |
| Deferred Revenue (Non-current) | 15M | 13M | 0 | 13M | 0 |
| Other Non-current Liabilities | 2.65B | 2.91B | 2.84B | 1.81B | 2.91B |
| Total Non-current Liabilities | 18.21B | 18.07B | 18.04B | 16.08B | 16.24B |
| Total Liabilities | 23.32B | 22.55B | 22.8B | 20.39B | 20.7B |
| Common Stock | 8M | 8M | 8M | 8M | 8M |
| Retained Earnings | (1.21B) | (803M) | (192M) | 3.01B | 4.42B |
| Accumulated OCI | (233M) | (181M) | (181M) | (180M) | (181M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 3.23B | 3.47B | 3.9B | 4.38B | 4.75B |
| Total Equity | 4.26B | 4.61B | 5.51B | 8.55B | 8.97B |
| Total Debt | 15.65B | 15.08B | 15B | 14.33B | 13.17B |
| Net Debt | 13.28B | 14.22B | 13.77B | 11.31B | 10.29B |
Tenet Healthcare Corporation
NYSE:THC
Intrinsic Alpha fair value
Locked
Current Price
$271.34
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.